Edgewise Therapeutics, Inc. (EWTX)
30.44
+0.78
(+2.63%)
USD |
NASDAQ |
Feb 27, 16:00
30.00
-0.44
(-1.45%)
After-Hours: 05:07
Edgewise Therapeutics Research and Development Expense (TTM) : 149.30M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Glaukos Corp. | 150.61M |
| Nuvalent, Inc. | 306.97M |
| Neurocrine Biosciences, Inc. | 1.016B |
| Omeros Corp. | 84.14M |
| Agios Pharmaceuticals, Inc. | 334.36M |